Showing 2551-2560 of 2652 results for "".
- China’s NMPA Accepts NDA for IBI-305, a Biosimilar Product Candidate of Bevacizumab (Avastin)https://modernod.com/news/chinas-nmpa-accepts-nda-for-ibi-305-a-biosimilar-product-candidate-of-bevacizumab-avastin/2479596/Innovent Biologics announced that the National Medical Products Administration (NMPA) has accepted its new drug application (NDA) for a biosimilar product candidate of bevacizumab (Avastin). This NDA by Innovent is the third that has been accepted by the NMPA following Tyvyt (sintilimab injectio
- Burnout Rises Above 50% in Some Specialties, New Survey Showshttps://modernod.com/news/burnout-rises-above-50-in-some-specialties-new-survey-shows/2476179/Responses to a new Medscape survey indicate that 44% of physicians meet the criteria for burnout, up from 42% in last year’s report. In addition, 11% are colloquially depressed (feeling down or sad), and 4% are clinically depressed, according to the
- Allergan, Mohawk Tribe Ask for Supreme Court Review of Scrutinized Patent Casehttps://modernod.com/news/allergan-mohawk-tribe-ask-for-supreme-court-review-of-scrutinized-patent-case/2476180/Allergan and the St. Regis Mohawk Tribe aim to continue their legal battle in defense of a controversial patent agreement struck a little over a year ago, appealing last week to the Supreme Court to review a federal appeals court decision which had undermined the deal’s main r
- Analysts Believe M&A Activity in the Pharmaceutical Sector Could Rise in 2019https://modernod.com/news/analysts-believe-ma-activity-in-the-pharmaceutical-sector-could-rise-in-2019/2476194/Analysts and investors hinted that M&A activity among drugmakers could increase in 2019 compared to the prior year, Business Insider reported
- Tiny Digital ‘Tags’ Improve Eye Care by Tracking Every Stephttps://modernod.com/news/tiny-digital-tags-improve-eye-care-by-tracking-every-step/2476201/Technology that retailers use to make a shopping experience more efficient could also benefit your next eye appointment. Called radiofrequency identification, or RFID, the tool helps streamline operations by knowing where everything is and where everything goes. It can help a large store m
- FDA Approved Record Number of Drugs in 2018https://modernod.com/news/fda-approved-record-number-of-drugs-in-2018/2476204/Last year was a banner year for the FDA, with 59 new drugs approved by the Center for Drug Evaluation and Research (CDER), including 19 first-in-class agents, 34 novel drugs for rare diseases, and a record seven biosimilars, according to a rep
- Staar Surgical Expects Fourth Quarter ICL Sales to Rise 42%; China Units Nearly Double, U.S. Market Returns to Growthhttps://modernod.com/news/staar-surgical-expects-fourth-quarter-icl-sales-to-rise-42-china-units-nearly-double-u-s-market-returns-to-growth/2476216/Staar Surgical, which provided preliminary sales results for the fourth quarter ending December 28, 2018, said it expects fourth quarter ICL net sales to increase approximately 42% over the prior year period. Total net sales for the fourth quarter are expected to be approximately $31.2 million an
- Oculogica Receives FDA Marketing Approval for EyeBOX, the First Noninvasive, Baseline-Free Test for Concussionhttps://modernod.com/news/oculogica-receives-fda-marketing-approval-for-eyebox-the-first-noninvasive-baseline-free-test-for-concussion/2476218/Oculogica announced that the FDA granted their De Novo request for the commercialization of EyeBOX, the first noninvasive, baseline-free tool to aid in the diagnosis of concussion. Oculogica plans to market the device for use in pediatrics ages 5 and older and adults up to 67 years o
- Oculis In-Licenses Phase 2 Topical Anti-TNF Alpha Antibody From Novartishttps://modernod.com/news/oculis-in-licenses-phase-2-topical-anti-tnf-alpha-antibody-from-novartis/2476220/Oculis has entered into an agreement to in-license a novel topical anti-TNF alpha antibody from Novartis. Terms of the deal were not disclosed. The compound, named LME 636, is based on a proprietary single-chain antibody fragment technology specifically de
- Unum Poll Finds 40 Percent of Adults Spend 12+ Hours on Devices Each Dayhttps://modernod.com/news/unum-poll-finds-40-percent-of-adults-spend-12-hours-on-devices-each-day/2476235/It’s the time of year when many Americans resolve to eat healthier, get more exercise or save more money. But a new resolution in this digital-crazed culture should be to give your eyes a break from too much screen time. A recent poll by employee benefits company Unum found that 40 percent of U.S